Comprehensive lung cancer conference will share current, practical
information on novel agents and strategies
CRANBURY, N.J.–(BUSINESS WIRE)–#lungcancer–Physicians’ Education Resource® (PER®), a worldwide leading resource for
continuing medical education, announces the full agenda for the 20th
Annual International Lung Cancer Congress®. The congress will be
held July 25-27 at the Hyatt Regency Huntington Beach in California.
“We are so proud to be celebrating 20 years of educational excellence at
this year’s congress,” said Phil Talamo, president of PER®. “This is a
major milestone for PER®, and we wouldn’t be able to become one of the
most comprehensive and detailed educational lung cancer meetings in the
world without the support of our national and international faculty
members and participants who attend our International Lung Cancer
Congress® every year.”
The 20th Annual International Lung Cancer Congress® is a
three-day program for surgical, medical and radiation oncologists
interested in the treatment of patients with lung cancer. During this
meeting, the activity co-chairs—Drs. David R. Gandara and Roy S.
Herbst—will be joined by renowned international and national experts who
will present a series of cutting-edge lectures, case-based panel and
interactive discussions, a molecular tumor board and several Medical
Crossfire® programs on how oncologists can incorporate the latest data
on targeted agents, immunotherapy, surgery and radiation oncology in the
clinic. Additionally, Gandara and Herbst will present the 12th annual
Bonnie J. Addario Lung Cancer Foundation keynote lecture and award at
this year’s congress.
For more information and to view the agenda or register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care
through professional education and now furthers patient care and
treatment strategies on a wide variety of chronic illnesses and
diseases. In 2016, PER® initiated continuing medical
education (CME) programming in the cardiovascular and endocrinology
areas. While continuing to expand into topics outside oncology, PER®
remains the leading provider of live, online and print CME activities
related to oncology and hematology. The high-quality, evidence-based
activities feature leading distinguished experts who focus on the
application of practice-changing advances. PER® is accredited
by the Accreditation Council for Continuing Medical Education and the
California Board of Registered Nursing. PER® is part of the
Cranbury, New Jersey-based MJH Associates, Inc., family of businesses.
Learn more at http://www.gotoper.com
and http://www.mjhassoc.com.
Contacts
PER® Media
Alexandra Ventura, 609-716-7777, ext. 121
[email protected]
